CATTANEO, ANTONINO
 Distribuzione geografica
Continente #
NA - Nord America 39.998
EU - Europa 29.845
AS - Asia 22.206
SA - Sud America 3.084
AF - Africa 551
Continente sconosciuto - Info sul continente non disponibili 105
OC - Oceania 53
Totale 95.842
Nazione #
US - Stati Uniti d'America 39.323
IT - Italia 8.261
SG - Singapore 6.386
RU - Federazione Russa 6.067
CN - Cina 5.465
SE - Svezia 3.953
IE - Irlanda 3.230
KR - Corea 2.883
BR - Brasile 2.311
DE - Germania 2.008
TR - Turchia 1.876
UA - Ucraina 1.564
VN - Vietnam 1.534
HK - Hong Kong 1.312
GB - Regno Unito 1.242
FI - Finlandia 841
FR - Francia 693
IN - India 565
NL - Olanda 543
BD - Bangladesh 513
CH - Svizzera 421
CA - Canada 358
AT - Austria 327
AR - Argentina 250
IQ - Iraq 231
JP - Giappone 203
MX - Messico 181
ID - Indonesia 171
PK - Pakistan 170
ZA - Sudafrica 158
ES - Italia 139
BE - Belgio 136
VE - Venezuela 134
PL - Polonia 131
IL - Israele 111
EC - Ecuador 109
PH - Filippine 108
SA - Arabia Saudita 103
CO - Colombia 102
EU - Europa 92
UZ - Uzbekistan 92
MA - Marocco 78
MY - Malesia 64
AE - Emirati Arabi Uniti 57
TN - Tunisia 56
CL - Cile 54
JO - Giordania 51
EG - Egitto 48
KE - Kenya 45
DZ - Algeria 41
AU - Australia 40
LT - Lituania 39
PE - Perù 36
PY - Paraguay 35
AL - Albania 34
NP - Nepal 30
OM - Oman 28
RO - Romania 27
BO - Bolivia 26
TH - Thailandia 26
PS - Palestinian Territory 24
AZ - Azerbaigian 23
ET - Etiopia 23
CZ - Repubblica Ceca 22
LB - Libano 22
JM - Giamaica 21
RS - Serbia 21
UY - Uruguay 21
KZ - Kazakistan 20
TW - Taiwan 20
CR - Costa Rica 19
DK - Danimarca 19
TT - Trinidad e Tobago 16
SN - Senegal 15
BG - Bulgaria 14
HN - Honduras 14
LU - Lussemburgo 14
DO - Repubblica Dominicana 13
GE - Georgia 13
HU - Ungheria 13
IR - Iran 13
NO - Norvegia 12
PA - Panama 12
GR - Grecia 11
NI - Nicaragua 11
KG - Kirghizistan 10
AO - Angola 9
KH - Cambogia 9
LY - Libia 9
NZ - Nuova Zelanda 9
SY - Repubblica araba siriana 9
BH - Bahrain 8
BY - Bielorussia 8
GT - Guatemala 8
KW - Kuwait 8
PT - Portogallo 8
XK - ???statistics.table.value.countryCode.XK??? 8
BW - Botswana 7
CI - Costa d'Avorio 7
QA - Qatar 7
Totale 95.662
Città #
Pisa 5.759
Ashburn 4.277
Dallas 3.708
Jacksonville 3.416
Singapore 3.332
Chandler 3.259
Dublin 3.224
San Jose 3.009
Seoul 2.867
Boardman 2.150
Council Bluffs 1.729
Moscow 1.549
Wilmington 1.357
Izmir 1.306
Hong Kong 1.189
Hefei 1.048
Ann Arbor 928
Beijing 828
Boston 776
New York 725
Los Angeles 692
Millbury 681
The Dalles 664
Düsseldorf 529
Kent 494
San Mateo 462
Istanbul 443
Amsterdam 440
Lauterbourg 435
Ho Chi Minh City 429
Bern 367
Mestre 367
Hanoi 328
Bremen 320
Milan 317
Lawrence 316
Seattle 315
Munich 303
Vienna 303
Ogden 296
Helsinki 295
Santa Clara 244
Woodbridge 235
São Paulo 209
Princeton 204
Chicago 193
Washington 192
Buffalo 191
North Bergen 181
Scuola 177
Dearborn 172
Saint Petersburg 167
Orem 165
Dong Ket 163
Tokyo 160
Guangzhou 154
Rome 147
Toronto 135
Brussels 128
Frankfurt am Main 126
Shanghai 126
Columbus 116
San Paolo di Civitate 114
Warsaw 113
Chennai 112
Brooklyn 103
Montreal 102
Jakarta 95
Turku 95
London 91
Baghdad 89
Atlanta 86
Wuhan 85
Houston 82
Fairfield 81
Da Nang 80
Stockholm 78
Johannesburg 77
Tashkent 77
Denver 74
Holon 70
Mexico City 65
Norwalk 60
Dhaka 59
Las Vegas 57
Manchester 57
Rio de Janeiro 57
Nanjing 56
Belo Horizonte 53
Mumbai 52
San Francisco 52
Lahore 51
San Giuliano Terme 51
Haiphong 48
Phoenix 48
Brasília 45
Caracas 45
Amman 43
Kunming 43
Andover 42
Totale 61.505
Nome #
Initial events leading to ß amyloid expression in anti-NGF transgenic mice. 2.645
A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration 1.223
A quantitative bioassay to determine the inhibitory potency of NGF-TrkA antagonists 1.125
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 396
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 389
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 383
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 375
A new intramolecular biosensor reveals Tau conformational changes in pathological conditions 367
Activity-dependent expression of Channelrhodopsin at neuronal synapses 360
Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate 358
Ligand signature in the membrane dynamics of single TrkA receptor molecules 350
A functional domain on the aloha-latrotoxin molecule, distinct from the binding site, involved in cathecolamine secretion from PC12 cells: identification with monoclonal antibodies 338
Assessment of antibody library diversity through next generation sequencing and technical error compensation 334
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 333
NGF steers microglia toward a neuroprotective phenotype 330
Site-specific labeling of neurotrophins and their receptors via short and versatile peptide tags 328
Precursor and mature NGF live tracking: one versus many at a time in the axons 327
Alpha-synuclein fret biosensors reveal early alpha-synuclein aggregation in the endoplasmic reticulum 325
Single molecule tracking and spectroscopy unveils molecular details in function and interactions of membrane receptors 322
A recombinant cell line expressing a form of the Y13-259 anti-p21ras antibody which binds protein A and may be produced as ascites 320
An Optimized Procedure for the Site-Directed Labeling of NGF and proNGF for Imaging Purposes 320
Gene Expression of Disease-related Genes in Alzheimer's Disease is Impaired by Tau Aggregation 320
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 318
Ligand-induced dynamics of neurotrophin receptors investigated by single-molecule imaging approaches 316
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 313
Corrigendum: Precursor and mature NGF live tracking: one versus many at a time in the axons 310
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 304
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 293
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 293
A non-radioactive in situ hybridization method that does not require RNAse-free conditions 292
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice 292
A new generation of NGF-based therapy for Alzheimer’s disease 290
Single Molecule Imaging and Tracking of Neurotrophins and their Receptors in Living Neuronal Cells 290
Fluorolabeling of the PPTase-Related Chemical Tags: Comparative Study of Different Membrane Receptors and Different Fluorophores in the Labeling Reactions 289
Fast-diffusing p75NTR monomers support apoptosis and growth cone collapse by neurotrophin ligands 288
'Phytoantibodies': a general vector for the expression of immunoglobulin domains in transgenic plants 285
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 285
Site-specific biotinylation of neurotrophins and their receptors by the insertion of short versatile peptide tags 284
A new mechanism for Alzheimer Neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 283
A triheptanoin-supplemented diet rescues hippocampal hyperexcitability and seizure susceptibility in FoxG1+/− mice 281
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 281
A protein silencing switch by ligand-induced proteasome targeting intrabodies 280
A small molecule targeting the multifactorial nature of Alzheimer's disease 280
A new generation of non invasive NGF-based therapies for Alzheimer’s Disease 279
Alzheimer-like neurodegeneration in anti-Nerve Growth Factor transgenic mice 279
A critical period in the sensitivity of basal forebrain cholinergic neurones to NGF deprivation 278
Conformational Rigidity within Plasticity Promotes Differential Target Recognition of Nerve Growth Factor 274
Abeta-Dependent Inhibition of LTP in Different Intra-Cortical Circuits of the Visual Cortex: The role of RAGE 273
Ligand Fingerprinting in the Membrane Dynamics of Single TrkA and P75NTR Neurotrophin Receptors 273
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 272
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 272
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 271
Large differences in aging phenotype between strains of the short-lived annual fish Nothobranchius furzeri 269
Mapping potentiated synapses in the hippocampus during acquisition and consolidation of a contextual fear memory 268
The conundrum of the high-affinity NGF binding site formation unveiled? 267
IGF-1 Restores Visual Cortex Plasticity in Adult Life by Reducing Local GABA Levels 265
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 265
Post-translational selective intracellular silencing of acetylated proteins with de novo selected intrabodies 265
Nerve growth factor derivative NGF61/100 promotes outgrowth of primary sensory neurons with reduced signs of nociceptive sensitization 264
Purification and proteomic profiling of PSD-95 intereactors at in vivo potentiated synapses 263
Tau Modulates VGluT1 Expression 263
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 258
Temperature affects longevity and age-related locomotor and cognitive decay in the short-lived fish Nothobranchius furzeri 251
PISA screening protocol – A protocol for the selection of intracellular antibodies against post-translational modifications of native proteins 251
A microglial function for the nerve growth factor : predictions of the unpredictable 250
Targeting the cation-chloride co-transporter NKCC1 to re-establish GABAergic inhibition and an appropriate excitatory/inhibitory balance in selective neuronal circuits: a novel approach for the treatment of Alzheimer's disease 250
Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes 250
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 249
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 249
Cortical Seizures in FoxG1 +/− mice are accompanied by akt/s6 overactivation, excitation/inhibition imbalance and impaired synaptic transmission 249
A macromolecular structure favouring microtubule assembly in NGF-differentiated pheochromocytoma cells (PC12) 248
Abeta (1-42) impairs LTP in mous eneocortex through RAGE mediated activation of p38 MAP kinase 248
Antibodies to nerve growth factor (NGF) prolong the sensitive period for monocular deprivation in the rat 247
proNGF/NGF mixtures induce gene expression changes in PC12 cells that neither singly produces 247
Human TrkAR649W mutation impairs nociception, sweating and cognitive abilities : a mouse model of HSAN IV 246
Site-specific direct labeling of neurotrophins and their receptors: From biochemistry to advanced imaging applications 246
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 245
Single particle tracking of acyl carrier protein (ACP)-tagged TrkA receptors in PC12nnr5 cells 245
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 245
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 245
A continuous model of physiological prion aggregation suggests a role for Orb2 in gating long-term synaptic information 245
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 244
TANEZUMAB, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain 244
The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells 244
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 243
Identification of an ERK Inhibitor as a Therapeutic Drug Against Tau Aggregation in a New Cell-Based Assay 242
Delivery of NGF to the Brain: Intranasal Versus Ocular Administration in Anti-NGF Transgenic Mice 241
“Annual fishes of the genus Nothobranchius as a model system for aging research” 240
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 239
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology 238
A humanized anti-NGF antibody with analgesic properties 238
Conformational targeting of intracellular Amyloid-beta oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum 237
ProNGF Is a Cell-Type-Specific Mitogen for Adult Hippocampal and for Induced Neural Stem Cells 235
Alzheimer-like neurodegeneration in aged anti-Nerve Growth Factor (NGF) mice 234
Non-Canonical Roles of Tau and Their Contribution to Synaptic Dysfunction 233
Effect of Chemical Vapor Deposition WS2 on Viability and Differentiation of SH-SY5Y Cells 233
Environmental enrichment rescues visual memory deficits in a mouse model of Alzheimer disease 231
An unbalance of proNGF/NGF signalling determines AD-like neurodegeneration in mice. 230
In vivo selection of intrabodies specifically targeting protein-protein interactions: a general platform for an “undruggable” class of disease targets 229
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 227
Totale 32.041
Categoria #
all - tutte 395.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 395.530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021697 0 0 0 0 0 0 0 0 0 0 0 697
2021/20223.691 387 30 40 241 245 67 82 336 247 203 126 1.687
2022/202315.413 1.024 827 600 1.087 925 1.530 9 3.998 4.737 91 241 344
2023/20244.848 793 128 507 144 283 990 186 198 597 170 36 816
2024/202519.194 2.303 385 656 1.976 2.125 320 1.471 806 2.975 837 2.514 2.826
2025/202637.005 2.292 3.246 4.887 3.480 2.291 1.542 5.765 2.409 5.177 2.690 1.724 1.502
Totale 96.576